Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer

Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer

US Patent 11364264 · Granted Jun 21, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Localized delivery of anti-fugetactic agent for treatment of cancer2024
Antigen-binding fusion proteins with modified HSP70 domains2023
Antigen-binding fusion proteins with modified HSP70 domains2023
Coxiella burnetii epitopes for T cell-targeted Q fever vaccines2023
CXCR4/CXCR7 blockade and treatment of human papilloma virus-associated disease2023
CXCR4/CXCR7 blockade and treatment of human papilloma virus-associated disease2023
HSP fusion protein with anti-chemorepellant agent for treatment of infectious di2022
HSP fusion protein with anti-chemorepellant agent for treatment of infectious di2022
Modified natural killer cells for the treatment of cancer2022
HSP fusion protein with anti-chemorepellant agent for treatment of cancer2022
HSP fusion protein with anti-chemorepellant agent for treatment of cancer2022
Anti-fugetactic agent and anti-cancer agent combination therapy and compositions2022